The mobile and “apps” market has been growing rapidly and steadily for the past few years. With the introduction of the iPad in 2010, the tablet market is gaining attention as product value soars in many industries. Health and pharmaceuticals is one of those industries openly accepting the mobile and tablet takeover as these devices and their “apps” bring added benefit and new innovative solutions. In a follow up to last week’s post,Arithmos discusses the market and how devices are being integrated.
The pharmaceutical industry has been embracing these markets for several reasons. One of the biggest reasons is patient compliance. Patients want the “WOW Factor ” – the digital and personalized experience.
Devices such as tablets and smartphones can cut clinical trial costs as well. Setting up desktops or laptops, or even printing paper, can be more expensive than simply downloading information on a device. Using these devices also allows patients to just send information via click or an IM/SMS. With the installation of ”apps”, medical information can be downloaded instantly by doctors or Investigators.